Date Published
Country
Source
Videos
close
-
J&J Discontinues Selling Talc-Based Baby Powders in U.S. & Canada
CNBC's Dominic Chu reports that J&J will now discontinue selling talc-based baby powders in the U.S. and Canada. -
Four Drug Companies Reach Last Minute Opioid Settlement with Ohio Counties
CNBC's Meg Tirrell reports on a last-minute settlement by four drug companies to avoid a federal lawsuit filed by two Ohio counties.Comments
-
Purdue Pharma in Talks With DOJ to Resolve Criminal, Civil Probes
Purdue Pharma is in talks with the Department of Justice to resolve its probes. The DOJ has considered charges used to prosecute drug dealers.Comments
-
US Population Decimated by Opioid Overdoses
A US judge has just ordered pharmaceutical giant Johnson & Johnson to pay the state of Oklahoma a $572 million fine for its role in the opioid crisis ravaging the United States.Comments
-
Here's What the Future May Hold for Purdue Pharma and Drug Industry
Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion.Comments
-
Not Sure One Pharmaceutical Company Should be Held Responsible for Opioid Crisis: Hassan
Fred Hassan, chairman of Caret Group and former CEO of Schering-Plough, joins CNBC's "Closing Bell" to discuss an Oklahoma judge's decision against Johnson & Johnson.Comments
-
Drugmakers Sue to Prevent Disclosure of Drug Prices in TV Ads
CNBC's Meg Tirrell reports on a new lawsuit from drugmakers against having to disclose prices in television graphics.Comments
-
Opioid Drugmaker Insys Files for Bankruptcy
CNBC's Meg Tirrell reports on Insys Therapeutics' possible criminal role in opioid crisis as company files for bankruptcy protection.Comments
-
Forty-four States Accuse Teva Pharmaceutical of Inflating Drug Prices
Forty-four U.S. states, led by Connecticut Attorney General William Tong, claim that 20 drug companies, including Teva USA, "systematically" divided up the market for generic drugs to avoid competing with one another.Comments
-
Pharmaceutical Company Lawsuit Reveals Behind the Scene Manipulations of Opioid Sales
A leading pharmaceutical company at the center of national opioid litigation in a Cleveland federal court is being accused of behind the scene manipulation of opioid sales in a separate lawsuit filed in Massachusetts.Comments
-
Pharmaceutical Company Lawsuit Reveals Behind the Scene Manipulations of Opioid Sales
A leading pharmaceutical company at the center of national opioid litigation in a Cleveland federal court is being accused of behind the scene manipulation of opioid sales in a separate lawsuit filed in Massachusetts.Comments
-
Balancing Drug Pricing With Value
The rising cost of prescription drugs is leading many recent headlines. However, a narrow focus on increased costs alone fails to capture how innovative therapies may offer patients considerable value relative to existing therapies.
Comments